BioCentury
ARTICLE | Company News

Sanofi endocrine/metabolic news

September 16, 2013 7:00 AM UTC

The U.S. District Court for the District of Utah ruled in Schubert v. Genzyme Corp. that Sanofi's Genzyme unit was under no affirmative duty to supply Fabry's disease therapy Fabrazyme agalsidase be...